Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)

China flag China · Delayed Price · Currency is CNY
75.32
+1.84 (2.50%)
Apr 24, 2025, 2:45 PM CST
26.59%
Market Cap 29.89B
Revenue (ttm) 2.95B
Net Income (ttm) 880.92M
Shares Out 406.80M
EPS (ttm) 2.16
PE Ratio 34.05
Forward PE 25.37
Dividend 0.41 (0.52%)
Ex-Dividend Date May 23, 2024
Volume 3,279,664
Average Volume 3,162,728
Open 72.80
Previous Close 73.48
Day's Range 72.80 - 75.32
52-Week Range 46.30 - 88.38
Beta 0.23
RSI 43.99
Earnings Date Mar 28, 2025

About Xiamen Amoytop Biotech

Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China. The company provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is based in Xiamen, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1996
Employees 1,960
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688278
Full Company Profile

Financial Performance

In 2024, Xiamen Amoytop Biotech's revenue was 2.82 billion, an increase of 34.13% compared to the previous year's 2.10 billion. Earnings were 827.60 million, an increase of 49.00%.

Financial Statements

News

There is no news available yet.